The role of IRF4 in regulating effector CD8+T cell development via repression of EOMES expression

被引:0
|
作者
Nayar, Ribhu [1 ]
Enos, Megan [1 ]
Prince, Amanda [1 ]
Shin, Hyun Mu [1 ]
Hemmers, Saskia
Klein, Ulk [3 ]
Rudensky, Alexander [2 ]
Berg, Leslie [1 ]
机构
[1] UMass Med Sch, Worcester, MA USA
[2] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA
[3] Columbia Univ, New York, NY USA
来源
JOURNAL OF IMMUNOLOGY | 2012年 / 188卷
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Expression of IRF8, IRF4, and MYC in Blastic Plasmacytoid Dendritic Cell Neoplasm
    Van Slambrouck, C. M.
    Gurbuxani, S.
    MODERN PATHOLOGY, 2014, 27 : 383A - 383A
  • [22] Expression of IRF8, IRF4, and MYC in Blastic Plasmacytoid Dendritic Cell Neoplasm
    Van Slambrouck, C. M.
    Gurbuxani, S.
    LABORATORY INVESTIGATION, 2014, 94 : 383A - 383A
  • [23] Role of CD4+T, CD8+T Cells, and CD4+T/CD8+T Cell Ratio in Gastric Cancer and Its Clinical Significance
    Han, Jingqi
    Zhao, Linglin
    Wu, Jianying
    Diao, Yinzhuo
    Guo, Qijing
    Yang, Jie
    Luo, Yushuang
    Applied Bionics and Biomechanics, 2022, 2022
  • [24] IRF1 expression might be a biomarker of CD8+T cell infiltration in cutaneous melanoma
    Zhou, Shijie
    Lu, Chunli
    Liu, Gan
    Hu, Qinsheng
    Yang, Jinliang
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2022, 18 (12) : 1319 - 1327
  • [25] IRF4 and BATF are critical for CD8+ T-cell function following infection with LCMV
    Grusdat, M.
    McIlwain, D. R.
    Xu, H. C.
    Pozdeev, V. I.
    Knievel, J.
    Crome, S. Q.
    Robert-Tissot, C.
    Dress, R. J.
    Pandyra, A. A.
    Speiser, D. E.
    Lang, E.
    Maney, S. K.
    Elford, A. R.
    Hamilton, S. R.
    Scheu, S.
    Pfeffer, K.
    Bode, J.
    Mittruecker, H-W
    Lohoff, M.
    Huber, M.
    Haeussinger, D.
    Ohashi, P. S.
    Mak, T. W.
    Lang, K. S.
    Lang, P. A.
    CELL DEATH AND DIFFERENTIATION, 2014, 21 (07): : 1050 - 1060
  • [26] HPK1 inhibits CD8+T cell effector gene expression following T cell activation
    Ames, Rachel Y.
    Zhao, Rongqi
    Mace, Parker
    Grant, Adam
    Xie, Guorui
    Milestone, Heather
    Grandcolas, Molly
    Fang, Eva
    Kiosea, Nicolae
    Wong, Stephen
    Brovarney, Martin
    Jacobson, Scott
    Nebalasca, Danilo
    Arguello, Jorge
    Gomez, Blanca
    Kandala, Hiranmayee
    Ko, Michelle Y.
    Nguyen, Lan
    Robles, Omar
    Shibuya, Grant
    Shakhmin, Anton A.
    Tivitmahaisoon, Parcharee
    Vi-Anh Vu
    Younai, Ashkaan
    Zibinsky, Mikhail
    Subramanyam, Babu
    Poon, Daniel
    Ghomi, Mohsen Sabouri
    Wustrow, David J.
    Kassner, Paul D.
    Katibah, George E.
    Brockstedt, Dirk G.
    CANCER RESEARCH, 2024, 84 (06)
  • [27] IRF4 and BATF are critical for CD8+ T-cell function following infection with LCMV
    M Grusdat
    D R McIlwain
    H C Xu
    V I Pozdeev
    J Knievel
    S Q Crome
    C Robert-Tissot
    R J Dress
    A A Pandyra
    D E Speiser
    E Lang
    S K Maney
    A R Elford
    S R Hamilton
    S Scheu
    K Pfeffer
    J Bode
    H-W Mittrücker
    M Lohoff
    M Huber
    D Häussinger
    P S Ohashi
    T W Mak
    K S Lang
    P A Lang
    Cell Death & Differentiation, 2014, 21 : 1050 - 1060
  • [28] A new dynamic model of CD8+T effector cell responses via CD4+T helper-antigen presenting cells
    Xiang, J
    FASEB JOURNAL, 2005, 19 (04): : A413 - A413
  • [29] IRF4与BATF在LCMV刺激下对CD8+T细胞功能有重要影响
    李婧
    生理科学进展, 2015, 46 (01) : 42 - 42
  • [30] Suppression of Inflammasome Activation by IRF8 and IRF4 in cDCs is Critical for T cell Priming
    McDaniel, Margaret
    Pasare, Chandrashekhar
    JOURNAL OF IMMUNOLOGY, 2020, 204 (01):